Skip to content
PeptideAgent

Clinics in Virginia

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

What Virginia law means for peptide clinics: who may prescribe, whether pharmacies may compound GLP-1 drugs (limited), how to check a clinic, and verified listings.

Virginia at a glance

503A framework
Adds state-specific limits to the 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async allowed
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Verified clinics serving Virginia

No verified clinics serving Virginia are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Peptide access rules in Virginia

Yes. A Virginia resident can obtain FDA approved peptides such as semaglutide and tirzepatide from a Virginia-licensed prescriber, including by telemedicine under the bona fide practitioner-patient relationship rules in Virginia Code section 54.1-3303, and can obtain a compounded peptide when it is dispensed by a pharmacy permitted or registered by the Virginia Board of Pharmacy and meets both federal 503A rules and Virginia's own compounding statute, section 54.1-3410.2. Nonresident pharmacies must register under section 54.1-3434.1, name a Virginia-licensed pharmacist in charge, and submit a recent home-state inspection showing USP compliance. [1] [2] [3] [4] [5] [6] [7] [8] [9]

Compounded GLP-1 access in Virginia

Out-of-state telehealth programs must dispense through a pharmacy registered under section 54.1-3434.1 with a Virginia-licensed pharmacist in charge. [4] [5] [12]

Research use only sellers in Virginia

The Virginia Drug Control Act restricts the sale and dispensing of Schedule VI (prescription-only) drugs to licensed practitioners and permitted or registered pharmacies, so injectable peptides sold to Virginia consumers as "research use only" are outside the licensed supply chain. [1] [6] [13]

Virginia notes on specific peptides

  • Semaglutide: A Schedule VI drug in Virginia, available branded by prescription, including after a real-time or store-and-forward telemedicine examination under section 54.1-3303. Compounded semaglutide is limited to the federal patient specific exception since the 503A grace period ended April 22, 2025. [3] [12]
  • BPC-157: Not FDA approved and not on the 503A bulks list. PCAC's July 2026 recommendation is advisory, and until FDA publishes a final rule a 503A pharmacy has no federal basis to compound it from bulk; a state board cannot authorize what federal law does not. Virginia's own bulk substance criteria in section 54.1-3410.2 add a second hurdle. [4] [10] [11]

How to check a clinic in Virginia

  1. Confirm the prescribing clinician's license with the Virginia medical or nursing board.
  2. Ask which pharmacy compounds or dispenses the peptide and check it in the Virginia Board of Pharmacy (Virginia Department of Health Professions) license lookup. [1] [4] [5] [7] [8] [9]
  3. Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Virginia. [1] [6] [13]

Common questions in Virginia

Can I get a GLP-1 prescription in Virginia through telemedicine?

Yes. Virginia Code section 54.1-3303 lets a Virginia-licensed prescriber establish a bona fide practitioner-patient relationship through real-time two-way communication or store-and-forward technology, as long as the standard of care does not require an in-person exam. The prescriber must still take a history, discuss risks and benefits, and arrange follow-up. [3]

All peptide legal questions for Virginia

Sources

  1. [1]Virginia Board of Pharmacy (Department of Health Professions)
  2. [2]Virginia Board of Medicine (Department of Health Professions)
  3. [3]Virginia Code section 54.1-3303, Prescriptions to be issued and drugs to be dispensed for medical or therapeutic purposes only
  4. [4]Virginia Code section 54.1-3410.2, Compounding
  5. [5]Virginia Code section 54.1-3434.1, Nonresident pharmacies to register with Board
  6. [6]Virginia Code section 54.1-3455, Schedule VI
  7. [7]18VAC110-20, Regulations governing the practice of pharmacy
  8. [8]18VAC110-20-321, Compounding
  9. [9]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  10. [10]FDA: Certain bulk drug substances for use in compounding may present significant safety risks (503A and 503B category lists)FDA